Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Smart Eye in connection with a capital procurement of MSEK 220
Mandate

Vinge advises Smart Eye in connection with a capital procurement of MSEK 220

November 01, 2021 Capital Markets and Public M&A

Vinge has advised Smart Eye Aktiebolag in connection with a directed new issue of shares to Swedish and international investors that contributed MSEK 220 to Smart Eye.

The subscription price of SEK 183 SEK, which corresponded to the closing price on Nasdaq First North Growth Market, was determined through an accelerated book-building procedure arranged by Carnegie. The proceeds will primarily be used to finance the acquisition of iMotions A/S, which was published on the same day.

Vinge’s team primarily consisted of Anders Strid, Edin Agic, Oscar Lunde and Adrian Filipovic.

Related

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge has advised Skeptiva AB in connection with its financing round

 Skeptiva is developing the next generation of cybersecurity defenses against fraud. The company has developed an AI application that detects attacks and alerts users in real time.
March 11, 2026

Vinge has advised Main Capital in connection with the acquisition of Good Solutions Sweden AB

 Good Solutions Sweden AB (”Good Solutions”) provides software that helps factories identify and reduce production losses. The software converts data from machines and operators into insights that can be used to streamline production and increase profitability.
March 11, 2026